Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity
João M. Santos, Camilla Heiniö, Víctor Cervera-Carrascón, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000188-e000188
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Chang Yang, Bairong Xia, Zhao-Cong Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 246
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
Yueshui Zhao, Jian Deng, Shuangfeng Rao, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4160-4160
Open Access | Times Cited: 99
New viral vectors for infectious diseases and cancer
Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano, et al.
Seminars in Immunology (2020) Vol. 50, pp. 101430-101430
Open Access | Times Cited: 86
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
Yaqi Zhao, Zheming Liu, Lan Li, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 67
Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy
Zong Sheng Guo, Michael T. Lotze, Zhi Zhu, et al.
Biomedicines (2020) Vol. 8, Iss. 7, pp. 204-204
Open Access | Times Cited: 56
Cytokines in oncolytic virotherapy
Jonathan Pol, Samuel T. Workenhe, Prathyusha Konda, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 56, pp. 4-27
Open Access | Times Cited: 53
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Jitka Fučíková, An Coosemans, Sandra Oršulić, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e002873-e002873
Open Access | Times Cited: 46
An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
Kai Ye, Fan Li, Ruikun Wang, et al.
Molecular Therapy (2022) Vol. 30, Iss. 12, pp. 3658-3676
Open Access | Times Cited: 37
Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer
James H.A. Clubb, Tatiana V. Kudling, Camilla Heiniö, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Adenovirus as a Vector and Oncolytic Virus
Wataru Matsunaga, Akinobu Gotoh
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4826-4840
Open Access | Times Cited: 18
Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
Xu Huang, Xiaoyu Li, Wulin Shan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 17
Oncolytic Adenovirus in Cancer Immunotherapy
Malin Peter, Florian Kühnel
Cancers (2020) Vol. 12, Iss. 11, pp. 3354-3354
Open Access | Times Cited: 43
Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer
Yuedi Zhang, Qiulin Cui, Manman Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression
Tatiana V. Kudling, James H.A. Clubb, Dafne C.A. Quixabeira, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours
Lydia G. White, Hannah E. Goy, Alinor J. Rose, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 978-978
Open Access | Times Cited: 23
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy
Hongbin Wang, Mia C. Borlongan, Akseli Hemminki, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 17-18, pp. 878-895
Open Access | Times Cited: 15
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer
Tatiana V. Kudling, James H.A. Clubb, Santeri A. Pakola, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 13
The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy?
Shunchuan Zhang, Samuel D. Rabkin
Expert Opinion on Drug Discovery (2020) Vol. 16, Iss. 4, pp. 391-410
Open Access | Times Cited: 36
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers
João M. Santos, Camilla Heiniö, Dafne C.A. Quixabeira, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 978-978
Open Access | Times Cited: 27
Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy
Elina Khatoon, Parama Dey, Aviral Kumar, et al.
Life Sciences (2022) Vol. 306, pp. 120827-120827
Closed Access | Times Cited: 20
Oncolytic Virus‐Driven Biotherapies from Bench to Bedside
Shijie Duan, Shuhang Wang, Lei Qiao, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 12
Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors
Lin Fang, Sen Yuan, Meng Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review
Fulvio Borella, Marco Carosso, Maria Pia Chiparo, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 140-140
Open Access
Recent advances in oncolytic virus combined immunotherapy in tumor treatment
Xiaoli Zhou, Shunfeng Hu, Xin Wang
Genes & Diseases (2025), pp. 101599-101599
Open Access
Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes
Tatiana V. Kudling, Dmitrii Bychkov, James H.A. Clubb, et al.
Cancer Gene Therapy (2025)
Open Access
Page 1 - Next Page

Scroll to top